title: Barriers of thrombolysis therapy in developing countries.
abstract: The developing world carries the highest burden of stroke mortality and stroke-related disability. The number of stroke patients receiving r-tPA in the developing world is extremely low. Prehospital delay, financial constraints, and lack of infrastructure are main barriers of thrombolysis therapy in developing countries. Until a cheaper thrombolytic agent and the proper infrastructure for utilization of thrombolytic therapy is available, developing countries should focus on primary and secondary stroke prevention strategies. However, governments and health systems of developing countries should efforts exerb for promotion of their infrastructure of stroke care.
authors: Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, P.O. Box: 91766-99199, Iran.
authors: Kavian
authors: K
authors: Ghandehari
references: Cerebrovasc Dis. 2006;22(5-6):423-8
references: 16912476
references: Acta Neurol Scand. 2006 Feb;113(2):121-4
references: 16411973
references: Neurosurgery. 2001 Jun;48(6):1344-7
references: 11383739
references: Int J Stroke. 2010 Feb;5(1):35-9
references: 20088992
references: Lancet. 2005 Jun 25-Jul 1;365(9478):2160-1
references: 15978910
references: Int J Stroke. 2010 Aug;5(4):238-56
references: 20636706
references: Neurol India. 2003 Dec;51(4):470-3
references: 14742924
references: Ethiop Med J. 2005 Oct;43(4):251-9
references: 16523645
references: Stroke. 2008 Nov;39(11):3036-41
references: 18703802
references: Int J Stroke. 2008 Aug;3(3):173-4
references: 18705895
references: Int J Stroke. 2007 Feb;2(1):17-26
references: 18705983
references: Cerebrovasc Dis. 2005;20(2):134-6
references: 16006762
references: Emerg Med J. 2007 Feb;24(2):96-9
references: 17251612
references: Int J Stroke. 2009 Aug;4(4):236
references: 19689746
references: Neurol India. 2007 Jan-Mar;55(1):46-9
references: 17272899
references: Clin Neurol Neurosurg. 2006 Sep;108(6):549-52
references: 16289309
references: J Stroke Cerebrovasc Dis. 2012 Jan;21(1):42-6
references: 22225863
references: Lancet Neurol. 2007 Jun;6(6):553-61
references: 17509490
references: Int J Stroke. 2009 Apr;4(2):89-93
references: 19383048
references: Neurol Sci. 2010 Apr;31(2):223-5
references: 19816656
references: J Neurol Sci. 2002 Jul 15;199(1-2):49-54
references: 12084442
references: Stroke. 2006 Aug;37(8):1997-2000
references: 16794214
references: Value Health. 2010 Jan-Feb;13(1):69-76
references: 19818059
references: Neurol India. 2006 Jun;54(2):152-6; discussion 156
references: 16804258
references: Stroke. 2000 Apr;31(4):882-5
references: 10753992
references: Neurol Res. 2006 Jan;28(1):11-5
references: 16464356
references: Circulation. 2005 Mar 15;111(10):1321-6
references: 15769775
references: Cerebrovasc Dis. 2007;23(2-3):132-9
references: 17124394
references: Orv Hetil. 2002 Nov 3;143(44):2479-84
references: 12674802
references: Int J Stroke. 2006 May;1(2):113-5
references: 18706058
references: Thromb Haemost. 2002 Mar;87(3):544-6
references: 11916094